Yikai Xu - Search Results

Year	Number of Results
2002	3
2003	1
2004	2
2005	1
2006	3
2007	5
2008	3
2009	7
2012	5
2013	4
2014	7
2015	8
2016	14
2017	21
2018	26
2019	28
2020	16
2021	24
2022	28
2023	31
2024	9

1

Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics.

Jiang Y, Zhou K, Sun Z, Wang H, Xie J, Zhang T, Sang S, Islam MT, Wang JY, Chen C, Yuan Q, Xi S, Li T, Xu Y, Xiong W, Wang W, Li G, Li R. Jiang Y, et al. Among authors: xu y. Cell Rep Med. 2023 Aug 15;4(8):101146. doi: 10.1016/j.xcrm.2023.101146. Epub 2023 Aug 8. Cell Rep Med. 2023. PMID: 37557177 Free PMC article.

2

Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial.

Wei X, Lin B, Huang Y, Yang S, Huang C, Shi L, Liu D, Zhang P, Lin J, Xu B, Guo D, Li C, He H, Liu S, Xue Y, Xu Y, Zhang H. Wei X, et al. Among authors: xu y. JAMA Netw Open. 2023 Mar 1;6(3):e233513. doi: 10.1001/jamanetworkopen.2023.3513. JAMA Netw Open. 2023. PMID: 36930148 Free PMC article. Clinical Trial.

3

Biology-guided deep learning predicts prognosis and cancer immunotherapy response.

Jiang Y, Zhang Z, Wang W, Huang W, Chen C, Xi S, Ahmad MU, Ren Y, Sang S, Xie J, Wang JY, Xiong W, Li T, Han Z, Yuan Q, Xu Y, Xing L, Poultsides GA, Li G, Li R. Jiang Y, et al. Among authors: xu y. Nat Commun. 2023 Aug 23;14(1):5135. doi: 10.1038/s41467-023-40890-x. Nat Commun. 2023. PMID: 37612313 Free PMC article.

4

Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer.

Huang W, Jiang Y, Xiong W, Sun Z, Chen C, Yuan Q, Zhou K, Han Z, Feng H, Chen H, Liang X, Yu S, Hu Y, Yu J, Chen Y, Zhao L, Liu H, Zhou Z, Wang W, Wang W, Xu Y, Li G. Huang W, et al. Among authors: xu y. Nat Commun. 2022 Aug 30;13(1):5095. doi: 10.1038/s41467-022-32816-w. Nat Commun. 2022. PMID: 36042205 Free PMC article.

5

Effect of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.

Zhang H, Hu D, Xu Y, Wu L, Lou L. Zhang H, et al. Among authors: xu y. Ann Med. 2022 Dec;54(1):262-273. doi: 10.1080/07853890.2021.1999494. Ann Med. 2022. PMID: 35037535 Free PMC article.

6

Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.

Jiang Y, Zhang Z, Yuan Q, Wang W, Wang H, Li T, Huang W, Xie J, Chen C, Sun Z, Yu J, Xu Y, Poultsides GA, Xing L, Zhou Z, Li G, Li R. Jiang Y, et al. Among authors: xu y. Lancet Digit Health. 2022 May;4(5):e340-e350. doi: 10.1016/S2589-7500(22)00040-1. Lancet Digit Health. 2022. PMID: 35461691 Free article.

7

Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy.

Huang C, Lin B, Chen C, Wang H, Lin X, Liu J, Ren Q, Tao J, Zhao P, Xu Y. Huang C, et al. Among authors: xu y. Adv Mater. 2022 Dec;34(51):e2207593. doi: 10.1002/adma.202207593. Epub 2022 Nov 18. Adv Mater. 2022. PMID: 36245299

8

Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer.

Sun Z, Zhang T, Ahmad MU, Zhou Z, Qiu L, Zhou K, Xiong W, Xie J, Zhang Z, Chen C, Yuan Q, Chen Y, Feng W, Xu Y, Yu L, Wang W, Yu J, Li G, Jiang Y. Sun Z, et al. Among authors: xu y. J Clin Invest. 2024 Jan 25;134(6):e175834. doi: 10.1172/JCI175834. J Clin Invest. 2024. PMID: 38271117 Free PMC article.

9

A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy.

Guo S, Xiong W, Zhu J, Feng J, Zhou R, Fan Q, Zhang Q, Li Z, Yang J, Zhou H, Yi P, Feng Y, Yang S, Qiu X, Xu Y, Shen Z. Guo S, et al. Among authors: xu y. Biomaterials. 2023 Nov;302:122300. doi: 10.1016/j.biomaterials.2023.122300. Epub 2023 Aug 29. Biomaterials. 2023. PMID: 37659110

10

Improved cancer immunotherapy strategies by nanomedicine.

Guo S, Feng J, Li Z, Yang S, Qiu X, Xu Y, Shen Z. Guo S, et al. Among authors: xu y. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1873. doi: 10.1002/wnan.1873. Epub 2022 Dec 28. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36576112 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

204 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Results by year